This contagious respiratory disease results in upwards of 80,000 hospitalizations in the United States annually among children aged younger than 5 years, and infants are especially vulnerable.
Both diseases have high rates of morbidity and mortality, so it is essential for pharmacists to be aware of guideline updates and recommended dosing regimens.